Technical Analysis for CLOV - Clover Health

Grade Last Price % Change Price Change
F 9.4 -3.19% -0.31
CLOV closed down 3.19 percent on Friday, February 26, 2021, on approximately normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Mar 1
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical CLOV trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -3.19%
New 52 Week Low Weakness -3.19%
Multiple of Ten Bearish Other -3.19%
Outside Day Range Expansion -3.19%
Wide Bands Range Expansion -3.19%
Oversold Stochastic Weakness -3.19%
Older End-of-Day Signals for CLOV ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. As a company whose business goals fully align with its members' health needs, Clover works with members and their doctors to become a valued partner. This trust is built by proactively identifying at-risk individuals and teaming up with physicians to accelerate care coordination and simultaneously improve health outcomes and reduce avoidable costs. Clover has offices in San Francisco, Jersey City, Nashville and Hong Kong.
Classification

Keywords: Health Informatics Patient Safety Healthcare Technology

Is CLOV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Date Title
Feb 28 Important Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Clover Health Investments, Corp. Investors of Important Deadline in Securities Fraud Class Action Lawsuit
Feb 28 SHAREHOLDER ALERT: SWI QS CLOV: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Feb 28 SPAC party may come to end soon, hedge fund manager warns
Feb 27 Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Clover Health Investments, Corp. - CLOV
Feb 27 HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Invites Clover Health Investments (CLOV) Investors with Losses to Contact its Attorneys, Securities Class Action Filed and Important Deadline Approaching
Feb 27 Kessler Topaz Meltzer & Check, LLP Reminds Clover Health Investments, Corp. Investors of Important Deadline in Securities Fraud Class Action Lawsuit
Feb 27 The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PEN, CLSK and CLOV
Feb 26 ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III Investors to Secure Counsel Before Important Deadline – CLOV, CLOVW, IPOC
Feb 26 INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Clover Health Investments, Corp. and Encourages Investors to Contact the Firm Before April 6, 2021
Feb 26 SHAREHOLDER ALERT: TCDA JFU CLOV: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
See more CLOV news...

Indicators

Indicator Value
52 Week High 17.45
52 Week Low 9.16
Average Volume 16,969,874
200-Day Moving Average 0.00
50-Day Moving Average 13.22
20-Day Moving Average 11.91
10-Day Moving Average 10.74
Average True Range 1.00
ADX 30.04
+DI 10.52
-DI 31.38
Chandelier Exit (Long, 3 ATRs ) 13.84
Chandelier Exit (Short, 3 ATRs ) 12.16
Upper Bollinger Band 14.72
Lower Bollinger Band 9.10
Percent B (%b) 0.05
BandWidth 47.19
MACD Line -0.99
MACD Signal Line -0.73
MACD Histogram -0.2646
Fundamentals Value
Market Cap 778.32 Million
Num Shares 82.8 Million
EPS -99999.99
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 0.00
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.66
Resistance 3 (R3) 10.72 10.36 10.45
Resistance 2 (R2) 10.36 10.04 10.33 10.38
Resistance 1 (R1) 9.88 9.84 9.70 9.82 10.31
Pivot Point 9.52 9.52 9.43 9.49 9.52
Support 1 (S1) 9.04 9.20 8.86 8.98 8.49
Support 2 (S2) 8.68 9.00 8.65 8.42
Support 3 (S3) 8.20 8.68 8.35
Support 4 (S4) 8.14